![TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/ceo/Michel_Vounatsos_owler_20210618_024449_original.jpg)
TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/ignyta_owler_20171222_073310_original.png)
TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/teva_owler_20161021_123931_original.png)
Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/amwell_owler_20211008_223058_original.png)
TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird](https://www.finanznachrichten.de/chart-formycon-ag-aktie-intraday-xetra.png)
DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird
![MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM](https://www.finanznachrichten.de/chart-medincell-sa-aktie-intraday-frankfurt.png)
MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM
![Harvest One Cannabis Inc.: Harvest One Continues International Expansion with Sales and Distribution Agreement for Dream Water and LivRelief Products in Africa Harvest One Cannabis Inc.: Harvest One Continues International Expansion with Sales and Distribution Agreement for Dream Water and LivRelief Products in Africa](https://www.finanznachrichten.de/chart-harvest-one-cannabis-inc-aktie-intraday-tradegate.png)